Literature DB >> 24803876

Early detection of hepatocellular carcinoma through surveillance using biomarkers.

Robert G Gish1.   

Abstract

Entities:  

Year:  2014        PMID： 24803876      PMCID： PMC4011377     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  4 in total

1.  Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma.

Authors:  Hidenori Toyoda; Takashi Kumada; Seiki Kiriyama; Yasuhiro Sone; Makoto Tanikawa; Yasuhiro Hisanaga; Akihiro Yamaguchi; Masatoshi Isogai; Yuji Kaneoka; Junji Washizu
Journal:  Clin Gastroenterol Hepatol       Date:  2006-01       Impact factor: 11.382

2.  Value of highly sensitive fucosylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment.

Authors:  Yasushi Tamura; Takeshi Suda; Shigeki Arii; Michio Sata; Fuminori Moriyasu; Hiroshi Imamura; Seiji Kawasaki; Namiki Izumi; Tadatoshi Takayama; Norihiro Kokudo; Masakazu Yamamoto; Hiroko Iijima; Yutaka Aoyagi
Journal:  Dig Dis Sci       Date:  2013-04-18       Impact factor: 3.199

3.  Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.

Authors:  Anna S Lok; Richard K Sterling; James E Everhart; Elizabeth C Wright; John C Hoefs; Adrian M Di Bisceglie; Timothy R Morgan; Hae-Young Kim; William M Lee; Herbert L Bonkovsky; Jules L Dienstag
Journal:  Gastroenterology       Date:  2009-10-20       Impact factor: 22.682

4.  Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3.

Authors:  Michael L Volk; Jose C Hernandez; Grace L Su; Anna S Lok; Jorge A Marrero
Journal:  Cancer Biomark       Date:  2007       Impact factor: 4.388
  4 in total
  5 in total

Review 1.  Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Mei Wang
Journal:  World J Hepatol       Date:  2015-01-27

2.  GPC-HCC model: a combination of glybican-3 with other routine parameters improves the diagnostic efficacy in hepatocellular carcinoma.

Authors:  Abdelfattah M Attallah; Mohamed El-Far; Mohamed M Omran; Mohamed A Abdelrazek; Ahmed A Attallah; Aya M Saeed; Khaled Farid
Journal:  Tumour Biol       Date:  2016-07-05

Review 3.  High-Throughput Analysis and Automation for Glycomics Studies.

Authors:  Archana Shubhakar; Karli R Reiding; Richard A Gardner; Daniel I R Spencer; Daryl L Fernandes; Manfred Wuhrer
Journal:  Chromatographia       Date:  2014-11-16       Impact factor: 2.044

4.  VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.

Authors:  Hiroaki Takaya; Tadashi Namisaki; Mitsuteru Kitade; Kosuke Kaji; Keisuke Nakanishi; Yuki Tsuji; Naotaka Shimozato; Kei Moriya; Kenichiro Seki; Yasuhiko Sawada; Soichiro Saikawa; Shinya Sato; Hideto Kawaratani; Takemi Akahane; Ryuichi Noguchi; Masanori Matsumoto; Hitoshi Yoshiji
Journal:  BMC Gastroenterol       Date:  2019-10-21       Impact factor: 3.067

5.  Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case-Control Study.

Authors:  Teerha Piratvisuth; Tawesak Tanwandee; Satawat Thongsawat; Wattana Sukeepaisarnjaroen; Juan Ignacio Esteban; Marta Bes; Bruno Köhler; Ying He; Magdalena Swiatek-de Lange; David Morgenstern; Henry Lik-Yuen Chan
Journal:  Hepatol Commun       Date:  2021-11-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.